Combination chemotherapy with temozolomide, lomustine, vincristine and interferon-alpha (TOL-IFN) plus vemurafenib or TOL-IFN as first-line treatment for patients with advanced melanoma

Kalle E. Mattila, Pia Vihinen, Susan Ramadan, Tanja Skyttä, Leena Tiainen, Meri-Sisko Vuoristo, Kristiina Tyynelä-Korhonen, Jussi Koivunen, Laura Kohtamäki, S Mäkelä, Siru Makela, Micaela Hernberg

    Research output: Contribution to journalArticleScientific

    5 Citations (Scopus)
    Original languageEnglish
    Pages (from-to)310-314
    JournalActa Oncologica
    Volume59
    Issue number3
    DOIs
    Publication statusPublished - 2019
    Publication typeB1 Journal article

    Cite this